Tag: Samsung Biologics

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Samsung Biologics

$19.81 Billion Large Molecule Drug Substance Contract - GlobeNewswire

Added to Collection on: 2024-05-14 14:33:39

Tags for this article:

Pharmaceutical industry
Pharmacy
Contract manufacturing organization
Drug manufacturing
Biopharmaceutical
Biosimilar
Samsung Biologics
Food and Drug Administration
WuXi Biologics
Catalent
Samsung
Medication

Click the tags to see associated articles and topics

View Article Details
AstraZeneca Loses Bid to Block Soliris Biosimilar During Appeal - Bloomberg Law News

Added to Collection on: 2024-06-18 16:30:25

Tags for this article:

Specialty drugs
Immunosuppressants
Monoclonal antibodies
Orphan drugs
Samsung
Samsung Biologics
Eculizumab
Alexion Pharmaceuticals
AstraZeneca
Biosimilar
Biopharmaceutical
Pharmaceutical industry in India
AstraZeneca plc
Alexion Pharmaceuticals Inc.
Samsung BioLogics Co

Click the tags to see associated articles and topics

View Article Details
Biologics Safety Testing Market worth $7.2 billion by 2029 - WhaTech

Added to Collection on: 2024-06-28 23:04:07

Tags for this article:

Pharmacy
Contract research organizations
Biotechnology
Biotechnology products
Biopharmaceutical
Pharmaceutical industry
Pharmaceutical industry in India
Thermo Fisher Scientific
Samsung Biologics
WuXi AppTec
Biocon
Merck Group

Click the tags to see associated articles and topics

View Article Details
Biologics Market Size To Reach $1,793.9 Billion By 2031 | CAGR 18.2%: The Insight Partners

Added to Collection on: 2024-10-24 14:36:01

Tags for this article:

Biotechnology
Biopharmaceutical
Pharmaceutical industry
Pharmacy
Samsung Biologics
WuXi Biologics
Biocon
Pharmaceutical industry in India
Food and Drug Administration
Vaccine
Contract manufacturing organization
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Samsung Biologics signs initial deal with LigaChem Bio on ADC production - KED Global

Added to Collection on: 2025-01-09 16:31:46

Tags for this article:

Biotechnology
Samsung
Samsung Biologics
Antibody-drug conjugate
Contract manufacturing organization
Biopharmaceutical
LigaChem Biosciences Inc.
Samsung Group

Click the tags to see associated articles and topics

View Article Details
UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform - Yahoo Finance

Added to Collection on: 2025-01-09 13:06:26

Tags for this article:

Biopharmaceutical
Biotechnology
Pharmaceutical industry
Pharmacy
UCB
Antibody
Artificial intelligence
Samsung Biologics
XtalPi Inc.
XtalPi Holdings Limited

Click the tags to see associated articles and topics

View Article Details
Global Biologics Drug Substance Manufacturing Market to Exhibit Growth at a CAGR of

Added to Collection on: 2025-02-05 22:41:29

Tags for this article:

Pharmacy
Samsung
Samsung Biologics
WuXi Biologics
Biopharmaceutical
Contract manufacturing organization
Pharmaceutical industry in India
WuXi AppTec
Biocon
Fujifilm Diosynth Biotechnologies
Catalent
Fujifilm
Drug Substance Manufacturing Market Company

Click the tags to see associated articles and topics

View Article Details
Pharmaceutical CDMO Market Size to Surge to USD 315.08 Bn by 2034 - BioSpace

Added to Collection on: 2025-02-05 15:34:35

Tags for this article:

Healthcare in India
Pharmaceutical industry in India
Contract manufacturing organization
Cambrex Corporation
Pharmaceutical industry in China
Samsung Biologics
Recipharm
Pharmaceutical industry
Samsung
Veranova
Hovione
Laurus Labs

Click the tags to see associated articles and topics

View Article Details
Cell Line Development Market Poised for Remarkable Growth, - openPR.com

Added to Collection on: 2025-03-22 19:13:56

Tags for this article:

Biotechnology
Biopharmaceutical
Pharmaceutical industry in India
Biosimilar
Biomanufacturing
Lonza Group
Cell culture
Stem cell
Monoclonal antibody
Samsung Biologics
Biotechnology in India

Click the tags to see associated articles and topics

View Article Details
Samsung Bioepis (CEO Kim Kyung-ah) announced on the 8th that it has launched its rare ...

Added to Collection on: 2025-04-08 01:44:30

Tags for this article:

Blood disorders
Monoclonal antibodies
Immunosuppressants
Specialty drugs
Orphan drugs
Eculizumab
Samsung Biologics
Atypical hemolytic uremic syndrome
Samsung
Hemolytic–uremic syndrome
Teva Pharmaceuticals
Biosimilar
samsung bioepis
United States
Teva

Click the tags to see associated articles and topics

View Article Details